Increased kynurenic acid production has been implicated in the pathology of schizophrenia. The findings provide a new target for cell-specific treatments that help reduce the production of kynurenic acid and reduce symptoms of schizophrenia.
Researchers report keeping levels of KYNA low throughout a worm's life can help prevent the onsite of age-related cognitive decline.
Adjusting levels of KYNA can have a significant effect on schizophrenia symptoms, a new study reports.
Researchers have identified a compound that appears to reverse the symptoms of Alzheimer's and Parkinson's disease in fruti flies. The findings may have significant implications for treating the diseases in humans.